Prodrugs activated by reactive oxygen species for use in the treatment of inflammatory diseases and cancer
Abstract
Prodrugs activated predominantly or exclusively in inflammatory tissue, more particularly prodrugs of methotrexate and derivatives thereof, which are selectively activated by Reactive Oxygen Species (ROS) in inflammatory tissues associated with cancer and inflammatory diseases, as well as method for preparing said prodrugs.
Info
Patent, 2018
UN SDG Classification
DK Main Research Area
Science/Technology
